Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H21Cl3N4O |
Molecular Weight | 451.777 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C=C1)C2CC(=NN2C3=C(Cl)C=C(Cl)C=C3)C(=O)NN4CCCCC4
InChI
InChIKey=WMMMJGKFKKBRQR-UHFFFAOYSA-N
InChI=1S/C21H21Cl3N4O/c22-15-6-4-14(5-7-15)20-13-18(21(29)26-27-10-2-1-3-11-27)25-28(20)19-9-8-16(23)12-17(19)24/h4-9,12,20H,1-3,10-11,13H2,(H,26,29)
Molecular Formula | C21H21Cl3N4O |
Molecular Weight | 451.777 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Rosonabant (E-6776) is a CB1-receptor antagonist that has appetite suppressant activity and was under development for the treatment of obesity. This preclinical anti-obesity drug shows activity that is similar to romonabant, a drug that was withdrawn from the European market due to severe side effects such as nausea, depression and suicidal ideations. Drug development of rosonabant has subsequently been halted.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:17:10 UTC 2023
by
admin
on
Fri Dec 15 17:17:10 UTC 2023
|
Record UNII |
7X5RY2T485
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29728
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000036917
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
11316914
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
DTXSID201006613
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
861151-12-4
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
7X5RY2T485
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
Rosonabant
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
8616
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY | |||
|
C90659
Created by
admin on Fri Dec 15 17:17:10 UTC 2023 , Edited by admin on Fri Dec 15 17:17:10 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|